Linguamatics text analytics helps Life Science companies to identify target genes with I2E

Gene-disease mapping & target identification

I2E helps you identify target genes for the diseases which interest you, and then rank them by factors such as safety and potential for therapeutic benefit


Linguamatics allows researchers to identify biomarkers with I2E text mining

Biomarker discovery

Researchers use I2E to understand which genes or other entities are potential biomarkers for particular diseases, and search and extract key information on interactions with various compounds


Drug development in a lab

Drug Development Safety and Pharmacovigilance

Valuable safety data are available in public databases and internal sources, but much of this is unstructured text. Linguamatics I2E platform transforms this text into actionable data that can be visualized and analyzed at every stage of the drug development process.


Linguamatics transforms real world data (RWD) with I2E Natural Language Processing

Transform Real World Data into insights

Real World Evidence (RWE) and Real World Data (RWD) can inform all phases of pharmaceutical drug development, commercialization, and drug use in healthcare settings


Analyse Life Sciences clinical trials for key insights with Linguamatics I2E NLP

Clinical trial analysis

Published clinical trials contain much valuable information but much of it is unstructured. With I2E you can extract key insights to help optimize future trial design and site selection


Linguamatics I2E text mining helps with patent landscaping for drug discovery pipelines

Patent landscape reporting & analysis

Understanding the drug discovery pipeline helps you maximize profit. I2E can be used to reveal which target areas have already attracted heavy investment and which offer potential for new drug candidates


Linguamatics ensure regulatory compliances for Life Sciences with I2E text mining software

Regulatory Compliance

The pharmaceutical industry is among the most heavily regulated in the world. Linguamatics I2E can bring time-saving benefits for regulatory compliance compared to manual efforts, which can be slow and expensive


Health economics and outcome research

Health economics and outcome research (HEOR)

Demonstrate clinical and economic evidence of benefit to decision-makers and funders

Gene annotation for NGS

Pharmacogenomics and personalized medicine

Detailed and focused gene profile annotations for Next Generation Sequencing (NGS) analysis

Mining Key opinion leaders

Key opinion leader identification

Scan unstructured published data sources to identify the top influencers in your sector

Drug repurposing

Identify new applications for existing drugs

Gene expression profile analysis

Explore the genetic basis of complex diseases

Analysis of news, social media & other online content

Internet data may be growing exponentially but I2E can get you to the insights you need